Abstract

Introduction Chromosomal microarray analysis (CMA) has currently been considered as the first-tier genetic test for patients with developmental delay/intellectual disability (DD/ID) in many countries. In this study, we performed an extensive assessment of the value of CMA for the diagnosis of children with ID/DD in China. Methods A total of 633 patients diagnosed with DD/ID in West China Second University Hospital, Sichuan University, were recruited from January 2014 to March 2019. The patients were classified into 4 subgroups: isolated DD/ID, DD/ID with multiple congenital anomalies (MCA), isolated autism spectrum disorders (ASDs), and DD/ID with epilepsy. CMA was performed on Affymetrix 750K platform. Results Among the 633 patients, 127 cases were identified as having pathogenic copy number variations (pCNVs) with an overall positive rate of 20.06%. Of the 127 cases with abnormal results, 76 cases had 35 types of microdeletion/microduplication syndromes (59.84%) including 5 cases caused by uniparental disomy (UPD), and 18 cases had unbalanced rearrangements (14.17%) including 10 cases inherited from parental balanced translocations or pericentric inversions. The diagnostic yields of pCNVs for the subgroups of isolated DD/ID, DD/ID with MCA, isolated ASD, and DD/ID with epilepsy were 18.07% (60/332), 34.90% (52/149), 3.70% (3/81), and 16.90% (12/71), respectively. The diagnostic yield of pCNVs in DD/ID patients with MCA was significantly higher than that of the other three subgroups, and the diagnostic yield of pCNVs in isolated ASD patients was significantly lower than that of the other three subgroups (p < 0.05). Conclusion Microdeletion/microduplication syndromes and unbalanced rearrangements are probably the main genetic etiological factors for DD/ID. DD/ID patients with MCA have a higher rate of chromosomal aberrations. Parents of DD/ID children with submicroscopic unbalance rearrangements are more likely to have chromosome balanced translocations or pericentric inversions, which might have been missed by karyotyping. CMA can significantly improve the diagnostic rate for patients with DD/ID, which is of great value for medical management and clinical guidance for genetic counseling.

Highlights

  • Chromosomal microarray analysis (CMA) has currently been considered as the first-tier genetic test for patients with developmental delay/intellectual disability (DD/ID) in many countries

  • Submicroscopic chromosomal aberrations play a significant role in the pathogenesis of DD/ID, and the diagnostic yield of chromosomal microarray analysis- (CMA-) detected CNVs associated with these disorders ranges from 12% to 29% [5,6,7,8]

  • The clinical utility of CMA has been recognized by several professional societies and has been recommended as the first-tier genetic test for patients with unexplained DD/ID, autism spectrum disorders (ASDs), and/or multiple congenital anomalies (MCAs) [9,10,11,12]

Read more

Summary

Introduction

Developmental delay/intellectual disability (DD/ID) affects approximately 3% of the general population [1]. Taking care of a patient with DD/ID exerts a substantial financial and emotional burden on his/her family and society. More than half of DD/ID cases resulted from genetic etiologies, including chromosomal abnormalities, microduplication or microdeletion syndromes, and monogenic disorders [3]. The clinical utility of CMA has been recognized by several professional societies and has been recommended as the first-tier genetic test for patients with unexplained DD/ID, autism spectrum disorders (ASDs), and/or multiple congenital anomalies (MCAs) [9,10,11,12]. We investigated 633 Chinese children with unexplained DD/ID combined with other conditions by the Affymetrix. TM ® CytoScan 750K Array over a period of 5 years and extensively assessed the value of CMA for the diagnosis of children with DD/ID

Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call